Ketamine Recruiting Phase 2 Trials for Vaso-Occlusive Crises / Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03296345Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis